BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Huang EM, Ma N, Ma T, Zhou JY, Yang WS, Liu CX, Hou ZH, Chen S, Zong Z, Zeng B, Li YR, Zhou TC. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma. World J Gastrointest Oncol 2022; 14(10): 1981-2003 [PMID: 36310708 DOI: 10.4251/wjgo.v14.i10.1981]
URL: https://www.wjgnet.com/1948-5182/full/v14/i10/1981.htm
Number Citing Articles
1
Lin Cheng, Shuhui Li, Deqi Jiang, Rongkai Sun, Yueshan Wang, Jianchao Zhang, Qiang Wei. Decreased levels of PTCSC3 promote the deterioration of prostate cancer and affect the prognostic outcome of patients through sponge miR-182-5pBMC Urology 2024; 24(1) doi: 10.1186/s12894-024-01531-7
2
Jia-qian Mo, Shen-yan Zhang, Qiang Li, Mo-xian Chen, Yue-qing Zheng, Xin Xie, Rongxin Zhang, Shan-shan Wang. Immunomodulation of cuproptosis and ferroptosis in liver cancerCancer Cell International 2024; 24(1) doi: 10.1186/s12935-023-03207-y
3
Kun Wang, Chunqian Yang, Jingen Xie, Xiao Zhang, Ting Wei, Zhu Yan. Long non-coding RNAs in ferroptosis and cuproptosis impact on prognosis and treatment in hepatocellular carcinomaClinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01397-x
4
Shang Rumin, Xiangming Han, Cui Zeng, Fei Lv, Rong Fang, Rongrong Gong, Xiaochang Tian, Xiangwu Ding, Miltiadis Paliouras. Systematic analysis of cuproptosis abnormalities and functional significance in cancerPLOS ONE 2024; 19(4): e0300626 doi: 10.1371/journal.pone.0300626
5
Daniela Gabbia, Sara De Martin. Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2023; 24(4): 3441 doi: 10.3390/ijms24043441
6
Pankaj Ahluwalia, Kalyani Ballur, Tiffanie Leeman, Ashutosh Vashisht, Harmanpreet Singh, Nivin Omar, Ashis K. Mondal, Kumar Vaibhav, Babak Baban, Ravindra Kolhe. Incorporating Novel Technologies in Precision Oncology for Colorectal Cancer: Advancing Personalized MedicineCancers 2024; 16(3): 480 doi: 10.3390/cancers16030480